BACKGROUND: Epidermal growth factor receptor (EGFR), characterized by its high positivity rate and strong specificity in triple-negative breast cancer (TNBC), has long been recognized as one of the characteristics of this subtype. The gene discussed is EGFR; the disease is triple-negative breast carcinoma.